PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Zhejiang Province, China.\', \'Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang Province, China.\', \'Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.\', \'Sorbonne Université, Saint-Antoine Hospital, AP-HP, and INSERM UMRs 938, Paris, France.\', \'Chaim Sheba Medical Center, Tel-Hashomer, Sackler School of Medicine, Tel Aviv University, Ramat Gan, Israel.\', \'Research Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom.\', \'Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang Province, China, huanghe@zju.edu.cn.\', \'Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China, huanghe@zju.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1159/000513036
?:doi
?:hasPublicationType
?:journal
  • Acta haematologica
is ?:pmid of
?:pmid
?:pmid
  • 33690228
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.575
?:rankingScore_hIndex
  • 53
?:title
  • How Do We Manage Hematopoietic Cell Transplant during the SARS-CoV-2 Pandemic?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all